Arovella Therapeutics Limited (ASX:ALA)

Intra-Cellular Therapies Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	11.75	12.71	5.18	6.07	6.72	0.98
Cash & Short-Term Investments	11.75	12.71	5.18	6.07	6.72	0.98
Cash Growth	146.70%	145.67%	-14.75%	-9.62%	587.20%	-77.34%
Accounts Receivable	-	-	0.01	0.04	0.01	0.22
Other Receivables	-	0.18	0	0	0.52	0.77
Receivables	-	0.18	0.01	0.04	0.53	0.99
Inventory	-	-	-	-	-	0.02
Prepaid Expenses	-	0.21	0.03	0.06	0.09	0.05
Other Current Assets	0.46	0.05	0.2	0.42	-	-
Total Current Assets	12.21	13.15	5.42	6.59	7.34	2.03
Property, Plant & Equipment	0.44	0.13	0.05	0.37	0.43	0.42
Other Intangible Assets	-	-	-	0.13	0.13	0.13
Long-Term Deferred Charges	-	-	-	2.12	2.78	4.12
Total Assets	12.65	13.28	5.47	9.21	10.69	6.71
Accounts Payable	0.73	0.98	0.77	0.75	0.23	0.73
Accrued Expenses	0.1	0.08	0.3	0.28	0.2	0.17
Current Portion of Leases	-	-	-	0.07	0.08	0.08
Current Unearned Revenue	-	0.14	0.15	0.34	0.2	0.33
Other Current Liabilities	0.25	0.84	0.45	0.06	1	0.7
Total Current Liabilities	1.09	2.04	1.68	1.51	1.69	2.02
Long-Term Leases	-	-	-	0.08	0	0
Other Long-Term Liabilities	0.02	0.02	0.01	0.01	0.01	0.55
Total Liabilities	1.11	2.06	1.69	1.6	1.71	2.57
Common Stock	105.62	104.3	88.87	83.54	77	67.39
Retained Earnings	-96.97	-95.51	-87.06	-77.02	-68.47	-64.88
Comprehensive Income & Other	2.88	2.44	1.96	1.11	0.45	1.63
Total Common Equity	11.54	11.23	3.78	7.62	8.98	4.14
Shareholders' Equity	11.54	11.23	3.78	7.62	8.98	4.14
Total Liabilities & Equity	12.65	13.28	5.47	9.21	10.69	6.71
Total Debt	-	-	-	0.14	0.08	0.09
Net Cash (Debt)	11.75	12.71	5.18	5.93	6.64	0.89
Net Cash Growth	146.70%	145.67%	-12.67%	-10.72%	644.16%	-79.06%
Net Cash Per Share	0.01	0.01	0.01	0.01	0.02	0.01
Filing Date Shares Outstanding	1,059	1,051	849.91	669.84	480.82	142.25
Total Common Shares Outstanding	1,059	1,051	849.91	669.84	480.82	142.25
Working Capital	11.12	11.11	3.74	5.08	5.65	0.01
Book Value Per Share	0.01	0.01	0.00	0.01	0.02	0.03
Tangible Book Value	11.54	11.23	3.78	7.48	8.85	4
Tangible Book Value Per Share	0.01	0.01	0.00	0.01	0.02	0.03
Machinery	-	0.34	0.25	1.07	1.19	1.03

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.